Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07169227 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Lidocaine, Paracetamol, and Dexmedetomidine for Rocuronium Injection Pain

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 11, 2025 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Propofol and rocuronium may cause pain during intravenous injection. Various pharmacological agents are used to reduce the incidence and severity of injection pain. Among the most commonly used agents for this purpose are lidocaine, various opioids, ketamine, paracetamol, and dexmedetomidine. The aim of this study was to evaluate the comparative effect of intravenous dexmedetomidine and paracetamol versus lidocaine in preventing propofol- and rocuronium-induced pain during anesthesia induction.
Trial Details
NCT Number NCT07169227
Lead Sponsor Baskent University
Conditions
(from sponsor)		 Propofol Injection Pain, Rocuronium Injection Pain
Enrollment 170 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov